Condition: Chronic Pain · Depressive Disorder · Anxiety Disorders · Sponsor: RIVER Foundation
A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic conditions who are receiving ketamine.
This description comes directly from the study's public registry record.
Ed Lesofski · 406-465-9504 · ed@riverofchange.org
James Taggart, MD · 415-713-6654 · jrtaggartmd@aol.com
Always discuss trial participation with your own doctor first.
| RIVER Telehealth | Helena, Montana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06038409